Clinikk: Financial Breakdown
Decoding financial health metrics of Clinikk
Total Revenue₹16.9 Cr+-78%Prev. FY
Total Expenses₹50.0 Cr+-41%Prev. FY
Profit After Tax₹-33.1 Cr+-221%Prev. FY
Total Assets₹25.4 Cr+-34%Prev. FY
Net Profit Margin-2.0%-1300%Prev. FY
FAQs on Financials of Clinikk
No. In FY23, Clinikk reported a net loss of ₹33.1 Cr+, so it was not profitable.
Clinikk's revenue declined 77.0% year-on-year, from ₹73.5 Cr+ in FY22 to ₹16.9 Cr+ in FY23.
Clinikk's estimated EBITDA for FY23 was ₹-29.2 Cr+, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY23, Clinikk posted revenue of ₹16.9 Cr+ (down 77.0% YoY) and a net loss of ₹33.1 Cr+. Explore the full financials of Clinikk here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links